JPRN-jRCT2080224074已完成3 期
Phase III study of BK1304 in healthy adults and adolescents
The Research Foundation for Microbial Diseases of Osaka University0 个研究点目标入组 1,500 人开始时间: 2018年10月2日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 1,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 13age old 至 <= 64age old（—）
- 性别
- All
入选标准
- •Written informed consent is obtained from subject/legal guardian
排除标准
- •Received BK1304 or intranasal administration of an inactivated influenza virus vaccine
- •History of influenza virus infection or influenza vaccination within 180 days prior to the first dose of study drug
- •History of anaphylaxis to food or drug
- •Judged ineligible for the study by investigator
研究者
相似试验
未知
2 期
Phase II study of BK1304 in healthy adultsPrevention of influenzaJPRN-jRCT2080223352The Research Foundation For Microbial Diseases Of Osaka University600
已完成
2 期
Phase 2 study of BK1304 in healthy childrePrevention of influenzaJPRN-jRCT2031200156Fuji Hideyuki120
未知
2 期
Safety of BK1301 in healthy adultsDiphtheria, Tetanus, Pertussis preventionJPRN-jRCT2080222663The Research Foundation for Microbial Diseases of Osaka University20
未知
3 期
A Long-term Phase III Study of TK-041 in Patients with Perennial Allergic RhinitisPerennial allergic rhinitisJPRN-jRCT2080222900TEIKOKU SEIYAKU CO., LTD.72
未知
3 期
A Phase III Long-Term Study of TK-041 in Patients with Pruritus Accompanied by Skin DiseasesJPRN-jRCT2080222735TEIKOKU SEIYAKU CO., LTD.180